Clinical evaluation of the QuantiFERON®-TB Gold test in patients with non-tuberculous mycobacterial disease

International Journal of Tuberculosis and Lung Disease

Volumn 13, Issue 11, 2009, Pages 1422-1426

  Kobashi, Y ^a   Mouri, K ^a   Yagi, S ^a   Obase, Y ^a   Miyashita, N ^a   Okimoto, N ^a   Matsushima, T ^b   Kageoka, T ^c   Oka, M ^a  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

^b Kurashiki Daiichi Hospital   (Japan)

^c KURASHIKI CENTRAL HOSPITAL   (Japan)

Author keywords

Non tuberculous mycobacterial (NTM) disease; QuantiFERON TB 2G (QFT 2G) test; Tuberculin skin test (TST)

Indexed keywords

BACTERIAL ANTIGEN; BIOLOGICAL MARKER; GAMMA INTERFERON;

ADULT; ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; FEMALE; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; MYCOBACTERIOSIS; MYCOBACTERIUM ABSCESSUS; MYCOBACTERIUM AVIUM; MYCOBACTERIUM CHELONEI; MYCOBACTERIUM INTRACELLULARE; MYCOBACTERIUM INTRACELLULARE AVIUM; MYCOBACTERIUM KANSASII; MYCOBACTERIUM MARINUM; MYCOBACTERIUM SZULGAI; NONTUBERCULOUS MYCOBACTERIAL DISEASE; PRACTICE GUIDELINE; PRIORITY JOURNAL; AGED; ANALYTICAL EQUIPMENT; ATYPICAL MYCOBACTERIOSIS; ATYPICAL MYCOBACTERIUM; BLOOD; CLINICAL TRIAL; DIFFERENTIAL DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; EVALUATION; IMMUNOLOGY; JAPAN; MICROBIOLOGY; MIDDLE AGED; MULTICENTER STUDY; PREDICTION AND FORECASTING; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS;

AGED; BIOLOGICAL MARKERS; DIAGNOSIS, DIFFERENTIAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERFERON-GAMMA; JAPAN; MALE; MIDDLE AGED; MYCOBACTERIA, ATYPICAL; MYCOBACTERIUM AVIUM-INTRACELLULARE INFECTION; MYCOBACTERIUM INFECTIONS, ATYPICAL; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; REAGENT KITS, DIAGNOSTIC; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS;

EID: 73949158264     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Mazurek G H, Jereb J, Lobue P, Iademarco M F, et al. Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States. MMWR 2005; 54 (RR-15): 49-56.
2. Pai M, Kalantri D, Dheda K. New tools and emerging technologies for the diagnosis of tuberculosis. Latent tuberculosis. Expert Rev Mol Diagn 2006; 6: 413-422.
3. Lalvani A. Diagnosing tuberculosis infection in the 21st century. New tools to tackle an old enemy. Chest 2007; 131: 1898-1906.
4. Arend S M, van Meijgaarden K E, de Boer K, et al. Tuberculin skin testing and in vitro T-cell responses to ESAT-6 and culture f ltrate protein 10 after infection with Mycobacterium mari-num or M. kansasii. J Infect Dis 2002; 186: 1797-1807.
5. Rothel J S, Andersen P. Diagnosis of latent Mycobacterium tuberculosis infection: is the demise of the Mantoux test imminent? Expert Rev Anti Infect Ther 2005; 3: 981-993.
6. Griffth D E, Akasamit T, Brown-Elliott B A, et al. An off cial ATS/IDSA statement: diagnosis, treatment, and prevention of non-tuberculous mycobacterial disease. Am J Respir Crit Care Med 2007; 175: 367-416.
7. McNabb A D, Eisler K, Adlie M, et al. Assessment of partial sequencing of the 65-kilodalton heat shock protein gene (hsp65) for routine identif cation of mycobacterium species isolated from clinical sources. J Clin Microbiol 2004; 42: 3000-3011.
8. Tortoli E. Impact of genotypic studies on mycobacterial taxonomy: the new mycobacteria of the 1990s. Clin Microbiol Rev 2003; 2: 319-354.
9. American Thoracic Society. Targeted tuberculin testing and treatment of latent tuberculosis infection. MMWR 2000; 49 (RR-6): 1-51.
10. Mori T, Sakatani M, Yamagishi F, et al. Specif c detection of tuberculosis infection: an interferon-gamma-based assay using new antigens. Am J Respir Crit Care Med 2004; 170: 59-64.
11. Kobashi Y, Obase Y, Fukuda M, et al. Clinical re-evaluation of the QuantiFERON TB-2G test as a diagnostic method for differentiating active tuberculosis from non-tuberculous myco-bacteriosis. Clin Infect Dis 2006; 43: 1540-1546.
12. Dewan P K, Grinsdale J, Kawamura L M. Low sensitivity of a whole-blood interferon-gamma release assay for detection of active tuberculosis. Clin Infect Dis 2007; 44: 69-73.
13. Arend S M, Andersen P, van Meijgaarden K E, et al. Detection of active tuberculosis infection by T-cell responses to early-s ecreted antigenic target 6-kDa protein and culture f ltrate protein 10. J Infect Dis 2000; 181: 1850-1854.
14. Richeldi L. An update on the diagnosis of tuberculosis infection. Am J Respir Crit Care Med 2006; 174: 736-742.